## Risk Factors for Oral Cavity Carcinoma **Key Point:** Oral cavity squamous cell carcinoma is multifactorial. The established risk factors include tobacco, alcohol, HPV, and areca nut chewing. Topical corticosteroid mouthwash is NOT a recognized risk factor. ### Established Risk Factors | Risk Factor | Mechanism | Prevalence in India | |---|---|---| | Tobacco (smoking, chewing) | Direct carcinogen; nitrosamines | Very high | | Alcohol (chronic) | Synergistic with tobacco; acetaldehyde | High | | Areca nut/betel leaf | Arecoline and nitrosamines; oral submucous fibrosis | Very high (endemic) | | HPV (types 16, 18) | Oncogenic proteins E6, E7; oropharyngeal SCC | Increasing | | Oral submucous fibrosis | Precancerous condition from areca nut | High in India | | Poor oral hygiene | Chronic inflammation | Moderate | | Nutritional deficiency (Fe, B12) | Plummer–Vinson syndrome | Moderate | **High-Yield:** The "big four" in India are tobacco, alcohol, areca nut, and HPV. Topical corticosteroid mouthwash is used therapeutically for oral inflammation and has no carcinogenic association. **Clinical Pearl:** Oral submucous fibrosis (OSF) from areca nut chewing is a precancerous condition with malignant transformation rate of 7–43% over 10 years. This is a major public health concern in India. **Warning:** Do not confuse topical corticosteroid use (safe, anti-inflammatory) with systemic immunosuppression (which increases cancer risk). Topical steroids are not a risk factor for oral SCC. ## Why the Correct Answer is Correct Topical corticosteroid mouthwash is an anti-inflammatory agent used to manage oral ulcers, lichen planus, and aphthous stomatitis. There is no epidemiological or mechanistic evidence linking topical corticosteroid mouthwash to oral cavity carcinoma. It is not a recognized risk factor in any major guideline (IARC, NCCN, ESMO).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.